The external urine management products market size was valued at USD 632.26 million in 2024 and is expected to reach USD 940.76 million by 2032, growing at a CAGR of 5.11% over 2025-2032.
To Get more information on Urine Management Products Market - Request Free Sample Report
The global external urine management products market is undergoing a significant transformation due to the increasing needs of an expanding elderly demographic, a mounting occurrence of urinary incontinence, and a preference toward non-invasive, catheter-free options. The global external urine management products market is rapidly growing due to increased comfort, less risk of catheter-associated urinary tract infections (CAUTIs), and greater patient mobility for both hospital and homecare facilities. There is increasing utilization of male and female external catheters, urine collection systems, and absorbent skin-friendly devices in the U.S. external urine management products market, particularly from post-acute and long-term care facilities.
In May 2024, TillaCare Ltd. announced that it received clearance from the FDA for UriCap Female, an advanced female external urine collection device that aims to reduce skin contact and incidence of infections, and provides impetus to the U.S. external urine management products market.
Technological innovation in skin-safe adhesives, hydrocolloid materials, and wearable urine sensors is spurring from the substantial growth in R&D investments by leading external urine management products companies that include Hollister Incorporated, Sage Products (Stryker), and TillaCare Ltd. Moreover, increasing investment in healthcare and favorable reimbursement coverage favor the expansion of the external urine management products market, while the development of wide supply chains facilitates better availability of advanced and disposable solutions in the regions.
The external urine management products market analysis in recent years emphasizes the role played by regulatory authorities, including the U.S. FDA and EMA, working to streamline approvals, especially for patient-friendly devices that serve to decrease infection risks and hospitalization. The global external urine management products market is supported by clinical data and pilot studies in nursing facilities, which promote wider use of CAUTI prevention bundles.
As per 2024 trends, health expenditure on products for incontinence care surged over 10% y-o-y in North America, with advancements in antimicrobial linings and urine diversion technology making products more user-friendly. The EEZS are based on the urinary incontinence kits of the US military and can be reused. Other companies, such as Consure Medical and Teleflex, have recently widened distribution in response to rising worldwide demand. Augmented promotional activities and online devices for managing incontinence are further contributing to the market’s future direction.
In March of 2024, Sage Products, a Stryker company, introduced next-generation male external urine devices with hydrogel adhesives for a secure fit, which exemplifies significant external urine management products market trends related to patient comfort and infection control.
Table: Regulatory Approvals and R&D Investments (2023–2025)
|
Company |
Year |
Product Approved |
Region |
R&D Focus Area |
|
Bright Uro |
2025 |
Glean Urodynamics System (FDA) |
U.S. |
Wireless, catheter-free diagnostics |
|
Medline & Consure |
2024 |
QiVi MEC Distribution Partnership |
North America |
Suction-based male urine devices |
|
TillaCare |
2023 |
UriCap Female (FDA Cleared) |
U.S. |
Female urine collection system |
Drivers:
Technological Advancements and Demand for Non-Invasive Solutions Driving Adoption Fuel Market Growth
Increasing demand for non-invasive and patient-friendly urinary incontinence products, including the aging population, after operations, is driving the external urine management product market growth. Recent awareness of the complications of indwelling catheters, including catheter-associated urinary tract infections (CAUTIs), has led to a move towards external devices. Devices designed to wick away moisture externally, real-time sensors to monitor for urine, and wearable technology that includes an ergonomic design have led to significantly more comfort, less risk of infection, and better compliance in these more recent innovations.
BioDerm Inc. and Men’s Liberty are among those companies that have diversified their offerings with gender-specific solutions that are made to be worn all day or night, with the maintenance of skin integrity. The increase in R&D investment is undeniable; BioDerm, for instance, grew its R&D expenditure by 18% in 2023 to underpin product development in secure, skin-friendly adhesive technology. In the meantime, regulatory incentives such as the CDC’s CAUTI reduction guidelines and the FDA’s 510(k) clearances have led to expedited market entry of innovative devices. In addition, hospital purchasing trends are moving towards value-based care, which supports the external urine management products market growth as a result of the decreased risk of hospitalization and fewer quality of life effects. With clinical preference and caretaker acceptance on the rise, the demand for external urine management products is growing, with strong product penetration in the global healthcare domain.
Restraints:
Product Limitations and Reimbursement Challenges Hindering Market Adoption
Despite increasing need, critical challenges exist in the external urine management products market in terms of product efficacy, skin issues, and lack of insurance coverage. A large group of patients complain of soiling, poor adhesion, and discomfort with long-term use, particularly with female-specific external solutions. These barriers impede caregiver reliance and repeated use. Moreover, Product availability, especially in remote and underdeveloped areas, is a challenge that can influence the external urine management products market share of hospitals and homecare providers.
An industry survey in 2024 showed that 32% of the caregivers consider external urine devices inappropriate for highly mobile or obese incontinent patients, suggesting a demand for a better form factor. In addition, reimbursement guidelines and coverage consistencies are still not ubiquitous globally. Most payers do not consider external devices as standard incontinence management options, resulting in higher out-of-pocket costs for patients. In the U.S., not all external urine devices are categorized as DME by CMS, which has hindered market adoption. While enhanced, regulatory pathways are still slow in approving labels for children or other high-risk populations. Furthermore, a lack of strong real-world evidence in certain patient segments also discourages the appetite for investment and development in niche segments, proving to be a major restraint on the external urine management products market analysis and longer-term expansion.
Segmentation Analysis:
By Products
The male external catheters were the largest product type segment in 2024 and accounted for a share of more than 65.12% of the global external urine management products market. This market share is in no small part due to ready access to men’s comfortable and skin-safe urine collection systems, which have been in use in hospitals and long-term care facilities for decades. These products are easier to fit, improve urine containment, and offer strong clinical evidence of their effectiveness in preventing CAUTIs. Furthermore, there has been a steady rise in innovation in adhesive technology and moisture management dedicated to male sufferers in the marketplace, which has fuelled demand.
The female external catheter segment is projected to register the highest growth in the forecast period, primarily due to growing emphasis on gender-inclusive devices and better device design for fitting every individual’s anatomy. There is growing investment by manufacturers in custom-fit products that will feature improved skin barriers and vacuum-based collection systems, thus overcoming historical issues in terms of leakage and comfort for female users.
By Distribution Channel
Offline was the dominant distribution channel with a share of over 57.25% of the global external urine management products market revenue in 2024. Hospitals, clinics, and medical supply outlets, however, still prefer to purchase in bulk through offline channels as they require immediate availability, product quality verification, and institutional contracts. This is where offline retail can offer consumers the ability to directly interact with healthcare professionals and receive more nuanced guidance on products and create trust, and, in turn, repeat purchase.
Nevertheless, the segment online is the fastest growing, with patients and caregivers fueled by quick and cheap online purchases driving towards E-commerce. Digital health platforms and specialty medical supply sites are broadening their product lines to offer subscription services and doorstep delivery and pushing use into home care and tech-savvy users.
By End-Use
The Hospitals segment accounted for over 45.7% share in the external urine management products market in 2024. Their leaders have a high admission rate of patients; the use of protocols of CAUTI prevention in most of the available health services, and working technical personnel for the placement of the external catheter. But hospitals remain the predominant proving ground, and clinical recommendations will largely determine their wider acceptance in the market.
On the other hand, home care is the fastest growing end-use segment of the market, driven by a growing geriatric population choosing home treatment and a shift towards patient-centred care. Growing demand for non-invasive urine management and incorporation with telemedicine and caregiver education in home settings is fueling demand for the products. Care products that are easy to apply and that can be applied independently reinforce this development.
North America held over 43.2% share of total revenue in 2024 in the global external urine management products market. This market leadership is accountable to the presence of superior health care facilities, higher availability and adoption of urological care solutions, and strong infection control practices within the hospitals.
The U.S. external urine management products market size was valued at USD 206.38 million in 2024 and is expected to reach USD 272.17 million by 2032, growing at a CAGR of 3.57% over 2025-2032. The U.S. is a major Contributor in the region, on account of the high adoption of CAUTI-prevention protocols on a large scale, favorable reimbursement policies, and high investment in R&D by companies (such as BD and Hollister) operating in the region. Weakening consumer awareness, low purchasing power, and government support and influence on home care services hamper sales. Canada is also contributing a major share in the market as the geriatric population is increasing, and also the patients living on home-based urinary care are very supportive. Meanwhile, increased distribution and public health spending in Mexico are leading to greater availability of products.
Europe is the second fastest growing geographic region in the market due to the ageing population, growing number of people affected with urinary incontinence, and entering the market, and because of its healthcare infrastructure and patient-centric innovations. The presence of established clinical protocols, government support for incontinence care products, and early use of external urinary devices in hospitals and elderly homes in developed countries such as Germany and the UK are among the leading countries. External catheters are in high demand among the elderly in Germany as a sector of the population with an especially high incidence of incontinence and for whom reimbursement rates are favorable. There is an increasing move towards home care in the UK, where the NHS is pushing for alternatives to long-term use of indwelling catheters. Moreover, increasing outreach initiatives in France and Spain, rising the caregiver uptake, will uplift the overall regional external urine management products market revenue.
Asia Pacific is estimated to be the fastest-growing region in the external urine management products market over the forecast period. This can be attributed to increasing awareness, increasing healthcare expenditures, and a growing aging population in countries such as China, India, and Japan.
Urbanization and better availability of healthcare in China, coupled with increased investments in care homes, are leading to higher adoption of products. India, with increasing capacity to manufacture medical devices and an increasing number of post-acute and home care setups, is becoming one of the potential growth hubs. Urinary management products are widely demanded for elderly care in Japan, where it faces the world's most aged society, and hospitals are increasingly introducing state-of-the-art non-invasive devices for the prevention of infection. Furthermore, developing governmental support for older population care and home-based treatments in South Korea and Australia is adding to growth in the regional external urine management products market.
Table: Regional Market Snapshot – Drivers & Adoption Levels (2024)
|
Region |
Market Position |
Dominant Country |
Key Driver |
|
North America |
Market Leader |
U.S. |
Hospital infrastructure, reimbursement |
|
Asia Pacific |
Fastest Growing |
China, India |
Aging population, homecare shift |
|
Europe |
Second Fastest Growing |
Germany, UK |
Elderly care support, product innovation |
|
Latin America |
Emerging |
Brazil |
Public-private health investments |
|
Middle East & Africa |
Developing |
Saudi Arabia |
Hospital expansion, awareness campaigns |
Get Customized Report as per Your Business Requirement - Enquiry Now
Leading external urine management products companies in the market include Cardinal Health, Coloplast Corp., Hollister Inc., BD (C. R. Bard), Teleflex Inc., B. Braun Melsungen AG, Consure Medical, Men’s Liberty (BioDerm), Sage Products (Stryker), and Boehringer Laboratories LLC, playing a vital role in innovation and market expansion.
In April 2025, Bright Uro received FDA 510(k) clearance for its Glean Urodynamics System, a wireless and catheter-free device providing ambulatory monitoring of lower urinary tract function, offering more physiologically accurate and comfortable diagnostics.
In April 2024, Medline announced an exclusive acute-care distribution agreement for the QiVi MEC male external urine management device, designed to reduce CAUTIs and incontinence-associated dermatitis through real-time suction and silicone-based adhesive.
| Report Attributes | Details |
|---|---|
| Market Size in 2024 | USD 632.26 million |
| Market Size by 2032 | USD 940.76 million |
| CAGR | CAGR of 5.11% From 2025 to 2032 |
| Base Year | 2024 |
| Forecast Period | 2025-2032 |
| Historical Data | 2021-2023 |
| Report Scope & Coverage | Market Size, Segments Analysis, Competitive Landscape, Regional Analysis, DROC & SWOT Analysis, Forecast Outlook |
| Key Segments | • By Products (Male External Catheters, Female External Catheters, and Urine Collection Accessories) • By Distribution Channel (Online, Offline) • By End-Use (Hospital, Clinics, Home care settings, and Others) |
| Regional Analysis/Coverage | North America (US, Canada, Mexico), Europe (Germany, France, UK, Italy, Spain, Poland, Turkey, Rest of Europe), Asia Pacific (China, India, Japan, South Korea, Singapore, Australia, Rest of Asia Pacific), Middle East & Africa (UAE, Saudi Arabia, Qatar, South Africa, Rest of Middle East & Africa), Latin America (Brazil, Argentina, Rest of Latin America) |
| Company Profiles | Cardinal Health, Coloplast Corp., Hollister Inc., BD (C. R. Bard), Teleflex Inc., B. Braun Melsungen AG, Consure Medical, Men’s Liberty (BioDerm), Sage Products (Stryker), and Boehringer Laboratories LLC |
Ans: Key drivers include rising hospital-acquired infection prevention efforts, aging populations, demand for non-invasive bladder management, and increasing adoption in homecare settings.
Ans: Top External Urine Management Products companies include Hollister Inc., Coloplast, BD (C. R. Bard), Teleflex, Consure Medical, and BioDerm (Men’s Liberty).
Ans: The market is segmented by product (male/female catheters, accessories), distribution channel (online/offline), and end-use (hospitals, clinics, homecare).
Ans: Male external catheters dominate due to ease of application and higher availability, while female devices are growing rapidly with design improvements.
Ans: Current External Urine Management Products market trends include wearable urine monitoring, skin-friendly adhesives, and increasing home-use product demand.
Table of Contents
1. Introduction
1.1 Market Definition
1.2 Scope (Inclusion and Exclusions)
1.3 Research Assumptions
2. Executive Summary
2.1 Market Overview
2.2 Regional Synopsis
2.3 Competitive Summary
3. Research Methodology
3.1 Top-Down Approach
3.2 Bottom-up Approach
3.3. Data Validation
3.4 Primary Interviews
4. Market Dynamics Impact Analysis
4.1 Market Driving Factors Analysis
4.1.1 Drivers
4.1.2 Restraints
4.1.3 Opportunities
4.1.4 Challenges
4.2 PESTLE Analysis
4.3 Porter’s Five Forces Model
5. Statistical Insights and Trends Reporting
5.1 Prevalence of Urinary Incontinence and Related Conditions (2024)
5.2 Product Usage and Adoption Trends (2024), by Region
5.3 Healthcare Spending and Reimbursement Trends, by Region (2024)
5.4 Infection Prevention & Device-Associated Complications Rates (2024)
5.5 Technological Advancements and Smart Device Integration
6. Competitive Landscape
6.1 List of Major Companies, By Region
6.2 Market Share Analysis, By Region
6.3 Product Benchmarking
6.3.1 Product specifications and features
6.3.2 Pricing
6.4 Strategic Initiatives
6.4.1 Marketing and promotional activities
6.4.2 Distribution and Supply Chain Strategies
6.4.3 Expansion plans and new Product launches
6.4.4 Strategic partnerships and collaborations
6.5 Technological Advancements
6.6 Market Positioning and Branding
7. External Urine Management Products Market Segmentation by Products
7.1 Chapter Overview
7.2 Male External Catheters
7.2.1 Male External Catheters Market Trends Analysis (2021-2032)
7.2.2 Male External Catheters Market Size Estimates and Forecasts to 2032 (USD Billion)
7.3 Female External Catheters
7.3.1 Female External Catheters Market Trends Analysis (2021-2032)
7.3.2 Female External Catheters Market Size Estimates and Forecasts to 2032 (USD Billion)
7.4 Urine Collection Accessories
7.4.1 Urine Collection Accessories Market Trends Analysis (2021-2032)
7.4.2 Urine Collection Accessories Market Size Estimates and Forecasts to 2032 (USD Billion)
8. External Urine Management Products Market Segmentation By Distribution Channel
8.1 Chapter Overview
8.2 Online
8.2.1 Online Market Trend Analysis (2021-2032)
8.2.2 Online Market Size Estimates and Forecasts to 2032 (USD Billion)
8.3 Offline
8.3.1 Offline Market Trends Analysis (2021-2032)
8.3.2 Offline Market Size Estimates and Forecasts to 2032 (USD Billion)
9. External Urine Management Products Market Segmentation By End Use
9.1 Chapter Overview
9.2 Hospital
9.2.1 Hospital Market Trends Analysis (2021-2032)
9.2.2 Hospital Market Size Estimates and Forecasts to 2032 (USD Billion)
9.3 Clinics
9.3.1 Clinics Market Trends Analysis (2021-2032)
9.3.2 Clinics Market Size Estimates and Forecasts to 2032 (USD Billion)
9.4 Home care settings
9.4.1 Home care settings Market Trends Analysis (2021-2032)
9.4.2 Home care settings Market Size Estimates and Forecasts to 2032 (USD Billion)
9.5 Others
9.5.1 Others Market Trends Analysis (2021-2032)
9.5.2 Others Market Size Estimates and Forecasts to 2032 (USD Billion)
10. Regional Analysis
10.1 Chapter Overview
10.2 North America
10.2.1 Trends Analysis
10.2.2 North America External Urine Management Products Market Estimates and Forecasts, by Country (2021-2032) (USD Billion)
10.2.3 North America External Urine Management Products Market Estimates and Forecasts, by Products (2021-2032) (USD Billion)
10.2.4 North America External Urine Management Products Market Estimates and Forecasts, By Distribution Channel (2021-2032) (USD Billion)
10.2.5 North America External Urine Management Products Market Estimates and Forecasts, By End Use (2021-2032) (USD Billion)
10.2.6 USA
10.2.6.1 USA External Urine Management Products Market Estimates and Forecasts, by Products (2021-2032) (USD Billion)
10.2.6.2 USA External Urine Management Products Market Estimates and Forecasts, By Distribution Channel (2021-2032) (USD Billion)
10.2.6.3 USA External Urine Management Products Market Estimates and Forecasts, By End Use (2021-2032) (USD Billion)
10.2.7 Canada
10.2.7.1 Canada External Urine Management Products Market Estimates and Forecasts, by Products (2021-2032) (USD Billion)
10.2.7.2 Canada External Urine Management Products Market Estimates and Forecasts, By Distribution Channel (2021-2032) (USD Billion)
10.2.7.3 Canada External Urine Management Products Market Estimates and Forecasts, By End Use (2021-2032) (USD Billion)
10.2.8 Mexico
10.2.8.1 Mexico External Urine Management Products Market Estimates and Forecasts, by Products (2021-2032) (USD Billion)
10.2.8.2 Mexico External Urine Management Products Market Estimates and Forecasts, By Distribution Channel (2021-2032) (USD Billion)
10.2.8.3 Mexico External Urine Management Products Market Estimates and Forecasts, By End Use (2021-2032) (USD Billion)
10.3 Europe
10.3.1 Trends Analysis
10.3.2 Europe External Urine Management Products Market Estimates and Forecasts, by Country (2021-2032) (USD Billion)
10.3.3 Europe External Urine Management Products Market Estimates and Forecasts, by Products (2021-2032) (USD Billion)
10.3.4 Europe External Urine Management Products Market Estimates and Forecasts, By Distribution Channel (2021-2032) (USD Billion)
10.3.5 Europe External Urine Management Products Market Estimates and Forecasts, By End Use (2021-2032) (USD Billion)
10.3.6 Germany
10.3.1.6.1 Germany External Urine Management Products Market Estimates and Forecasts, by Products (2021-2032) (USD Billion)
10.3.1.6.2 Germany External Urine Management Products Market Estimates and Forecasts, By Distribution Channel (2021-2032) (USD Billion)
10.3.1.6.3 Germany External Urine Management Products Market Estimates and Forecasts, By End Use (2021-2032) (USD Billion)
10.3.7 France
10.3.7.1 France External Urine Management Products Market Estimates and Forecasts, by Products (2021-2032) (USD Billion)
10.3.7.2 France External Urine Management Products Market Estimates and Forecasts, By Distribution Channel (2021-2032) (USD Billion)
10.3.7.3 France External Urine Management Products Market Estimates and Forecasts, By End Use (2021-2032) (USD Billion)
10.3.8 UK
10.3.8.1 UK External Urine Management Products Market Estimates and Forecasts, by Products (2021-2032) (USD Billion)
10.3.8.2 UK External Urine Management Products Market Estimates and Forecasts, By Distribution Channel (2021-2032) (USD Billion)
10.3.8.3 UK External Urine Management Products Market Estimates and Forecasts, By End Use (2021-2032) (USD Billion)
10.3.9 Italy
10.3.9.1 Italy External Urine Management Products Market Estimates and Forecasts, by Products (2021-2032) (USD Billion)
10.3.9.2 Italy External Urine Management Products Market Estimates and Forecasts, By Distribution Channel (2021-2032) (USD Billion)
10.3.9.3 Italy External Urine Management Products Market Estimates and Forecasts, By End Use (2021-2032) (USD Billion)
10.3.10 Spain
10.3.10.1 Spain External Urine Management Products Market Estimates and Forecasts, by Products (2021-2032) (USD Billion)
10.3.10.2 Spain External Urine Management Products Market Estimates and Forecasts, By Distribution Channel (2021-2032) (USD Billion)
10.3.10.3 Spain External Urine Management Products Market Estimates and Forecasts, By End Use (2021-2032) (USD Billion)
10.3.12 Poland
10.3.12.1 Poland External Urine Management Products Market Estimates and Forecasts, by Country (2021-2032) (USD Billion)
10.3.12.1 Poland External Urine Management Products Market Estimates and Forecasts, by Products (2021-2032) (USD Billion)
10.3.12.3 Poland External Urine Management Products Market Estimates and Forecasts, By Distribution Channel (2021-2032) (USD Billion)
10.3.12.3 Poland External Urine Management Products Market Estimates and Forecasts, By End Use (2021-2032) (USD Billion)
10.3.13 Turkey
10.3.13.1 Turkey External Urine Management Products Market Estimates and Forecasts, by Products (2021-2032) (USD Billion)
10.3.13.2 Turkey External Urine Management Products Market Estimates and Forecasts, By Distribution Channel (2021-2032) (USD Billion)
10.3.13.3 Turkey External Urine Management Products Market Estimates and Forecasts, By End Use (2021-2032) (USD Billion)
10.3.14 Rest of Europe
10.3.14.1 Rest of Europe External Urine Management Products Market Estimates and Forecasts, by Products (2021-2032) (USD Billion)
10.3.14.2 Rest of Europe External Urine Management Products Market Estimates and Forecasts, By Distribution Channel (2021-2032) (USD Billion)
10.3.14.3 Rest of Europe External Urine Management Products Market Estimates and Forecasts, By End Use (2021-2032) (USD Billion)
10.4 Asia-Pacific
10.4.1 Trends Analysis
10.4.2 Asia-Pacific External Urine Management Products Market Estimates and Forecasts, by Country (2021-2032) (USD Billion)
10.4.3 Asia-Pacific External Urine Management Products Market Estimates and Forecasts, by Products (2021-2032) (USD Billion)
10.4.4 Asia-Pacific External Urine Management Products Market Estimates and Forecasts, By Distribution Channel (2021-2032) (USD Billion)
10.4.5 Asia-Pacific External Urine Management Products Market Estimates and Forecasts, By End Use (2021-2032) (USD Billion)
10.4.6 China
10.4.6.1 China External Urine Management Products Market Estimates and Forecasts, by Products (2021-2032) (USD Billion)
10.4.6.2 China External Urine Management Products Market Estimates and Forecasts, By Distribution Channel (2021-2032) (USD Billion)
10.4.6.3 China External Urine Management Products Market Estimates and Forecasts, By End Use (2021-2032) (USD Billion)
10.4.7 India
10.4.7.1 India External Urine Management Products Market Estimates and Forecasts, by Products (2021-2032) (USD Billion)
10.4.7.2 India External Urine Management Products Market Estimates and Forecasts, By Distribution Channel (2021-2032) (USD Billion)
10.4.7.3 India External Urine Management Products Market Estimates and Forecasts, By End Use (2021-2032) (USD Billion)
10.4.8 Japan
10.4.8.1 Japan External Urine Management Products Market Estimates and Forecasts, by Products (2021-2032) (USD Billion)
10.4.8.2 Japan External Urine Management Products Market Estimates and Forecasts, By Distribution Channel (2021-2032) (USD Billion)
10.4.8.3 Japan External Urine Management Products Market Estimates and Forecasts, By End Use (2021-2032) (USD Billion)
10.4.9 South Korea
10.4.9.1 South Korea External Urine Management Products Market Estimates and Forecasts, by Products (2021-2032) (USD Billion)
10.4.9.2 South Korea External Urine Management Products Market Estimates and Forecasts, By Distribution Channel (2021-2032) (USD Billion)
10.4.9.3 South Korea External Urine Management Products Market Estimates and Forecasts, By End Use (2021-2032) (USD Billion)
10.4.10 Singapore
10.4.10.1 Singapore External Urine Management Products Market Estimates and Forecasts, by Products (2021-2032) (USD Billion)
10.4.10.2 Singapore External Urine Management Products Market Estimates and Forecasts, By Distribution Channel (2021-2032) (USD Billion)
10.4.10.3 Singapore External Urine Management Products Market Estimates and Forecasts, By End Use (2021-2032) (USD Billion)
10.4.11 Australia
10.4.11.1 Australia External Urine Management Products Market Estimates and Forecasts, by Products (2021-2032) (USD Billion)
10.4.11.2 Australia External Urine Management Products Market Estimates and Forecasts, By Distribution Channel (2021-2032) (USD Billion)
10.4.11.3 Australia External Urine Management Products Market Estimates and Forecasts, By End Use (2021-2032) (USD Billion)
10.4.12 Rest of Asia-Pacific
10.4.12.1 Rest of Asia-Pacific External Urine Management Products Market Estimates and Forecasts, by Products (2021-2032) (USD Billion)
10.4.12.2 Rest of Asia-Pacific External Urine Management Products Market Estimates and Forecasts, By Distribution Channel (2021-2032) (USD Billion)
10.4.12.3 Rest of Asia-Pacific External Urine Management Products Market Estimates and Forecasts, By End Use (2021-2032) (USD Billion)
10.5 Middle East and Africa
10.5.1 Trends Analysis
10.5.2 Middle East and Africa East External Urine Management Products Market Estimates and Forecasts, by Country (2021-2032) (USD Billion)
10.5.3 Middle East and Africa External Urine Management Products Market Estimates and Forecasts, by Products (2021-2032) (USD Billion)
10.5.4 Middle East and Africa External Urine Management Products Market Estimates and Forecasts, By Distribution Channel (2021-2032) (USD Billion)
10.5.5 Middle East and Africa External Urine Management Products Market Estimates and Forecasts, By End Use (2021-2032) (USD Billion)
10.5.6 UAE
10.5.6.1 UAE External Urine Management Products Market Estimates and Forecasts, by Products (2021-2032) (USD Billion)
10.5.6.2 UAE External Urine Management Products Market Estimates and Forecasts, By Distribution Channel (2021-2032) (USD Billion)
10.5.6.3 UAE External Urine Management Products Market Estimates and Forecasts, By End Use (2021-2032) (USD Billion)
10.5.7 Saudi Arabia
10.5.7.1 Saudi Arabia External Urine Management Products Market Estimates and Forecasts, by Products (2021-2032) (USD Billion)
10.5.7.2 Saudi Arabia External Urine Management Products Market Estimates and Forecasts, By Distribution Channel (2021-2032) (USD Billion)
10.5.7.3 Saudi Arabia External Urine Management Products Market Estimates and Forecasts, By End Use (2021-2032) (USD Billion)
10.5.8 Qatar
10.5.8.1 Qatar External Urine Management Products Market Estimates and Forecasts, by Products (2021-2032) (USD Billion)
10.5.8.2 Qatar External Urine Management Products Market Estimates and Forecasts, By Distribution Channel (2021-2032) (USD Billion)
10.5.8.3 Qatar External Urine Management Products Market Estimates and Forecasts, By End Use (2021-2032) (USD Billion)
10.5.9 South Africa
10.5.9 1 South Africa External Urine Management Products Market Estimates and Forecasts, by Products (2021-2032) (USD Billion)
10.5.9 2 South Africa External Urine Management Products Market Estimates and Forecasts By Distribution Channel (2021-2032) (USD Billion)
10.5.9 3 South Africa External Urine Management Products Market Estimates and Forecasts, By End Use (2021-2032) (USD Billion)
10.5.10 Rest of Middle East & Africa
10.5.10.1 Rest of Middle East & Africa External Urine Management Products Market Estimates and Forecasts, by Products (2021-2032) (USD Billion)
10.5.10.2 Rest of Middle East & Africa External Urine Management Products Market Estimates and Forecasts, By Distribution Channel (2021-2032) (USD Billion)
10.5.10.3 Rest of Middle East & Africa External Urine Management Products Market Estimates and Forecasts, By End Use (2021-2032) (USD Billion)
10.6 Latin America
10.6.1 Trends Analysis
10.6.2 Latin America External Urine Management Products Market Estimates and Forecasts, by Country (2021-2032) (USD Billion)
10.6.3 Latin America External Urine Management Products Market Estimates and Forecasts, by Products (2021-2032) (USD Billion)
10.6.4 Latin America External Urine Management Products Market Estimates and Forecasts, By Distribution Channel (2021-2032) (USD Billion)
10.6.5 Latin America External Urine Management Products Market Estimates and Forecasts, By End Use (2021-2032) (USD Billion)
10.6.6 Brazil
10.6.6.1 Brazil External Urine Management Products Market Estimates and Forecasts, by Products (2021-2032) (USD Billion)
10.6.6.2 Brazil External Urine Management Products Market Estimates and Forecasts, By Distribution Channel (2021-2032) (USD Billion)
10.6.6.3 Brazil External Urine Management Products Market Estimates and Forecasts, By End Use (2021-2032) (USD Billion)
10.6.7 Argentina
10.6.7.1 Argentina External Urine Management Products Market Estimates and Forecasts, by Products (2021-2032) (USD Billion)
10.6.7.2 Argentina External Urine Management Products Market Estimates and Forecasts, By Distribution Channel (2021-2032) (USD Billion)
10.6.7.3 Argentina External Urine Management Products Market Estimates and Forecasts, By End Use (2021-2032) (USD Billion)
10.6.8 Rest of Latin America
10.6.8.1 Rest of Latin America External Urine Management Products Market Estimates and Forecasts, by Products (2021-2032) (USD Billion)
10.6.8.2 Rest of Latin America External Urine Management Products Market Estimates and Forecasts, By Distribution Channel (2021-2032) (USD Billion)
10.6.8.3 Rest of Latin America External Urine Management Products Market Estimates and Forecasts, By End Use (2021-2032) (USD Billion)
12. Company Profiles
12.1 Cardinal Health
12.1.1 Company Overview
12.1.2 Financial
12.1.3 Products/ Services Offered
12.1.4 SWOT Analysis
12.2 Coloplast Corp.
12.2.1 Company Overview
12.2.2 Financial
12.2.3 Products/ Services Offered
12.2.4 SWOT Analysis
12.3 Hollister Inc.
12.3.1 Company Overview
12.3.2 Financial
12.3.3 Products/ Services Offered
12.3.4 SWOT Analysis
12.4 BD (C. R. Bard)
12.4.1 Company Overview
12.4.2 Financial
12.4.3 Products/ Services Offered
12.4.4 SWOT Analysis
12.5 Teleflex Inc.
12.5.1 Company Overview
12.5.2 Financial
12.5.3 Products/ Services Offered
12.5.4 SWOT Analysis
12.6 B. Braun Melsungen AG
12.6.1 Company Overview
12.6.2 Financial
12.6.3 Products/ Services Offered
12.6.4 SWOT Analysis
12.7 Consure Medical
12.7.1 Company Overview
12.7.2 Financial
12.7.3 Products/ Services Offered
12.7.4 SWOT Analysis
12.8 Men’s Liberty (BioDerm)
12.8.1 Company Overview
12.8.2 Financial
12.8.3 Products/ Services Offered
12.8.4 SWOT Analysis
12.9 Sage Products (Stryker)
12.9.1 Company Overview
12.9.2 Financial
12.9.3 Products/ Services Offered
12.9.4 SWOT Analysis
12.10 Boehringer Laboratories LLC
12.10.1 Company Overview
12.10.2 Financial
12.10.3 Products/ Services Offered
12.10.4 SWOT Analysis
12. Use Cases and Best Practices
13. Conclusion
An accurate research report requires proper strategizing as well as implementation. There are multiple factors involved in the completion of good and accurate research report and selecting the best methodology to compete the research is the toughest part. Since the research reports we provide play a crucial role in any company’s decision-making process, therefore we at SNS Insider always believe that we should choose the best method which gives us results closer to reality. This allows us to reach at a stage wherein we can provide our clients best and accurate investment to output ratio.
Each report that we prepare takes a timeframe of 350-400 business hours for production. Starting from the selection of titles through a couple of in-depth brain storming session to the final QC process before uploading our titles on our website we dedicate around 350 working hours. The titles are selected based on their current market cap and the foreseen CAGR and growth.
The 5 steps process:
Step 1: Secondary Research:
Secondary Research or Desk Research is as the name suggests is a research process wherein, we collect data through the readily available information. In this process we use various paid and unpaid databases which our team has access to and gather data through the same. This includes examining of listed companies’ annual reports, Journals, SEC filling etc. Apart from this our team has access to various associations across the globe across different industries. Lastly, we have exchange relationships with various university as well as individual libraries.
Step 2: Primary Research
When we talk about primary research, it is a type of study in which the researchers collect relevant data samples directly, rather than relying on previously collected data. This type of research is focused on gaining content specific facts that can be sued to solve specific problems. Since the collected data is fresh and first hand therefore it makes the study more accurate and genuine.
We at SNS Insider have divided Primary Research into 2 parts.
Part 1 wherein we interview the KOLs of major players as well as the upcoming ones across various geographic regions. This allows us to have their view over the market scenario and acts as an important tool to come closer to the accurate market numbers. As many as 45 paid and unpaid primary interviews are taken from both the demand and supply side of the industry to make sure we land at an accurate judgement and analysis of the market.
This step involves the triangulation of data wherein our team analyses the interview transcripts, online survey responses and observation of on filed participants. The below mentioned chart should give a better understanding of the part 1 of the primary interview.
Part 2: In this part of primary research the data collected via secondary research and the part 1 of the primary research is validated with the interviews from individual consultants and subject matter experts.
Consultants are those set of people who have at least 12 years of experience and expertise within the industry whereas Subject Matter Experts are those with at least 15 years of experience behind their back within the same space. The data with the help of two main processes i.e., FGDs (Focused Group Discussions) and IDs (Individual Discussions). This gives us a 3rd party nonbiased primary view of the market scenario making it a more dependable one while collation of the data pointers.
Step 3: Data Bank Validation
Once all the information is collected via primary and secondary sources, we run that information for data validation. At our intelligence centre our research heads track a lot of information related to the market which includes the quarterly reports, the daily stock prices, and other relevant information. Our data bank server gets updated every fortnight and that is how the information which we collected using our primary and secondary information is revalidated in real time.
Step 4: QA/QC Process
After all the data collection and validation our team does a final level of quality check and quality assurance to get rid of any unwanted or undesired mistakes. This might include but not limited to getting rid of the any typos, duplication of numbers or missing of any important information. The people involved in this process include technical content writers, research heads and graphics people. Once this process is completed the title gets uploader on our platform for our clients to read it.
Step 5: Final QC/QA Process:
This is the last process and comes when the client has ordered the study. In this process a final QA/QC is done before the study is emailed to the client. Since we believe in giving our clients a good experience of our research studies, therefore, to make sure that we do not lack at our end in any way humanly possible we do a final round of quality check and then dispatch the study to the client.
Key Segments
By Products
Male External Catheters
Female External Catheters
Urine Collection Accessories
By Distribution Channel
Online
Offline
By End-Use
Hospital
Clinics
Home care settings
Others
Request for Segment Customization as per your Business Requirement: Segment Customization Request
Regional Coverage:
North America
US
Canada
Mexico
Europe
Germany
France
UK
Italy
Spain
Poland
Turkey
Rest of Europe
Asia Pacific
China
India
Japan
South Korea
Singapore
Australia
Rest of Asia Pacific
Middle East & Africa
UAE
Saudi Arabia
Qatar
South Africa
Rest of Middle East & Africa
Latin America
Brazil
Argentina
Rest of Latin America
Request for Country Level Research Report: Country Level Customization Request
Available Customization
With the given market data, SNS Insider offers customization as per the company’s specific needs. The following customization options are available for the report:
Detailed Volume Analysis
Criss-Cross segment analysis (e.g., Product X Application)
Competitive Product Benchmarking
Geographic Analysis
Additional countries in any of the regions
Customized Data Representation
Detailed analysis and profiling of additional market players